These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 17323186

  • 1. Chemopreventive effect of celecoxib in gastric cancer.
    Futagami S, Suzuki K, Hiratsuka T, Shindo T, Hamamoto T, Ueki N, Kusunoki M, Miyake K, Gudis K, Tsukui T, Sakamoto C.
    Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
    [Abstract] [Full Text] [Related]

  • 2. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD, Zeng ZR, Hu PJ.
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [Abstract] [Full Text] [Related]

  • 3. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
    Hung KH, Yang HB, Cheng HC, Wu JJ, Sheu BS.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical Questions #6. Does celecoxib increase cardiovascular risk?
    Mayer BJ, Lamfers R, Feldstein DA.
    WMJ; 2005 Nov; 104(8):15-6. PubMed ID: 16425910
    [No Abstract] [Full Text] [Related]

  • 6. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
    Nam KT, Hahm KB, Oh SY, Yeo M, Han SU, Ahn B, Kim YB, Kang JS, Jang DD, Yang KH, Kim DY.
    Clin Cancer Res; 2004 Dec 01; 10(23):8105-13. PubMed ID: 15585646
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2008 Jul 15; 76(2):179-87. PubMed ID: 18547544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
    Ran JT, Zhou YN, Tang CW, Li HH, Li XW, Lu H.
    Ai Zheng; 2009 Apr 15; 28(4):361-5. PubMed ID: 19622294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of antinociceptive efficacy and gastroprotection between celecoxib and diclofenac plus misoprostol in rats.
    Reyes-García G, Déciga-Campos M, Medina-Santillan R, Granados-Soto V.
    Proc West Pharmacol Soc; 2007 Apr 15; 50():69-71. PubMed ID: 18605234
    [Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of celecoxib, a COX-2 selective inhibitor.
    Antoniou K, Malamas M, Drosos AA.
    Expert Opin Pharmacother; 2007 Aug 15; 8(11):1719-32. PubMed ID: 17685888
    [Abstract] [Full Text] [Related]

  • 14. Risks and benefits of celecoxib to prevent recurrent adenomas.
    Psaty BM, Potter JD.
    N Engl J Med; 2006 Aug 31; 355(9):950-2. PubMed ID: 16943408
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
    Noguchi M, Kimoto A, Kobayashi S, Yoshino T, Miyata K, Sasamata M.
    Eur J Pharmacol; 2005 Apr 25; 513(3):229-35. PubMed ID: 15862805
    [Abstract] [Full Text] [Related]

  • 17. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
    Bozzo F, Bassignana A, Lazzarato L, Boschi D, Gasco A, Bocca C, Miglietta A.
    Chem Biol Interact; 2009 Dec 10; 182(2-3):183-90. PubMed ID: 19682443
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action of celecoxib on normal and acid-challenged gastric mucosa.
    Dutta N, Sarotra P, Gupta S, Aggarwal R, Agnihotri N.
    Exp Toxicol Pathol; 2009 Jul 10; 61(4):353-61. PubMed ID: 19041231
    [Abstract] [Full Text] [Related]

  • 19. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication.
    Yang HB, Cheng HC, Sheu BS, Hung KH, Liou MF, Wu JJ.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):455-61. PubMed ID: 17270001
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP.
    He Q, Luo X, Jin W, Huang Y, Reddy MV, Reddy EP, Sheikh MS.
    Oncogene; 2008 Apr 17; 27(18):2656-60. PubMed ID: 17968315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.